Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published February 2008 | Published + Accepted Version
Journal Article Open

Nanotechnology and cancer


The biological picture of cancer is rapidly advancing from models built from phenomenological descriptions to network models derived from systems biology, which can capture the evolving pathophysiology of the disease at the molecular level. The translation of this (still academic) picture into a clinically relevant framework can be enabling for the war on cancer, but it is a scientific and technological challenge. In this review, we discuss emerging in vitro diagnostic technologies and therapeutic approaches that are being developed to handle this challenge. Our discussion of in vitro diagnostics is guided by the theme of making large numbers of measurements accurately, sensitively, and at very low cost. We discuss diagnostic approaches based on microfluidics and nanotechnology. We then review the current state of the art of nanoparticle-based therapeutics that have reached the clinic. The goal of the presentation is to identify nanotherapeutic strategies that are designed to increase efficacy while simultaneously minimizing the toxic side effects commonly associated with cancer chemotherapies.

Additional Information

"Reprinted, with permission, from the Annual Review of Medicine, Volume 59 copyright 2008 by Annual Reviews, www.annualreviews.org" First published online as a Review in Advance on October 15, 2007. Dr. Davis is a consultant and has stock in Calando Pharmaceuticals and Insert Therapeutics. Dr. Heath is on the board of Homestead Clinical Corp., which has obtained licensing rights to the DEAL technology.

Attached Files

Published - HEAarm08.pdf

Accepted Version - nihms478911.pdf


Files (1.3 MB)
Name Size Download all
408.3 kB Preview Download
870.6 kB Preview Download

Additional details

August 22, 2023
October 16, 2023